SCHEMBL7909956

SCHEMBL7909956

CCCC(CCC)(C(=O)N[C@@H](C)C1CCCCC1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.48
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
EPHX1 P07099 2/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
NTRK1 P04629 1/20 0.40
CCR1 P32246 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3145185 0.72 EPHX2 (0.47) EPHX2TAS1R3TAS1R1EPHX1LMNA
SCHEMBL27666301 0.71 TAS1R3 (0.55) EPHX2TAS1R3TAS1R1EPHX1LMNA
SCHEMBL27666303 0.71 TAS1R3 (0.55) EPHX2TAS1R3TAS1R1EPHX1LMNA
SCHEMBL7906007 0.71 ALDH1A1 (0.53) LMNACYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL24146311 0.70 EPHX2 (0.68) EPHX2TAS1R3TAS1R1PSEN1PSEN2
SCHEMBL3107097 0.70 CA12 (0.54) EPHX2TAS1R3TAS1R1EPHX1CA12
SCHEMBL19652079 0.68 CA12 (0.56) EPHX2TAS1R3TAS1R1EPHX1CYP3A4
SCHEMBL19836585 0.68 CA12 (0.56) EPHX2TAS1R3TAS1R1EPHX1CYP3A4
SCHEMBL4002970 0.68 TSHR (0.53) LMNACYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL19416190 0.68 EPHX2 (0.57) EPHX2TAS1R3TAS1R1NTRK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010106081-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-23 WO disclosed